Medicinal cannabis refers to cannabis-based products that are prescribed by a registered healthcare practitioner for the management of specific medical conditions and symptoms. Unlike recreational cannabis, medicinal cannabis is used within a healthcare framework, where treatment decisions are made by qualified practitioners and products are supplied through regulated pathways.
Over recent years, access to medicinal cannabis in Australia has expanded significantly as healthcare practitioners have become more familiar with cannabinoid-based therapies and patients have sought additional treatment options to complement traditional medical care.
Medicinal cannabis products may contain varying amounts of cannabinoids, including cannabidiol (CBD) and tetrahydrocannabinol (THC), depending on the individual treatment plan and the clinical circumstances of the patient.
The cannabis plant contains more than 100 naturally occurring compounds known as cannabinoids. These compounds interact with the body's endocannabinoid system, a complex biological network involved in maintaining balance across numerous physiological functions.
Two of the most commonly discussed cannabinoids are:
Cannabidiol (CBD)
CBD is a non-intoxicating cannabinoid found in cannabis. It does not produce the euphoric effects typically associated with recreational cannabis and is commonly included in many medicinal cannabis formulations.
Tetrahydrocannabinol (THC)
THC is the primary psychoactive cannabinoid found in cannabis. Depending on the product and dosage, THC may influence perception, mood, cognition and coordination. Products containing THC require careful clinical assessment and monitoring.
The human body contains a naturally occurring network known as the endocannabinoid system (ECS).
The ECS plays a role in regulating various functions including:
Sleep
Mood
Appetite
Memory
Immune responses
Pain perception
Stress responses
Researchers continue to study the ECS and its interaction with cannabinoids to better understand how cannabis-based medicines may fit within modern healthcare.
Medicinal cannabis is available in a variety of formulations.
Cannabis Oils
Cannabis oils are among the most commonly prescribed medicinal cannabis products. Oils allow healthcare practitioners to tailor cannabinoid ratios and dosages according to individual patient needs.
Capsules
Capsules provide a measured dose and may be suitable for patients seeking convenience and consistency.
Dried Flower
Dried cannabis flower may be prescribed in certain circumstances. Different flower varieties contain varying cannabinoid and terpene profiles.
Other Formulations
Depending on product availability and clinical circumstances, medicinal cannabis may also be supplied in other dosage forms including extracts, sprays and specialised formulations.
Medicinal cannabis products are regulated therapeutic goods.
Access generally occurs through healthcare practitioners who assess whether medicinal cannabis may be appropriate for a patient's circumstances.
Common pathways include:
Authorised Prescriber Pathway
Certain healthcare practitioners may become authorised to prescribe specific medicinal cannabis products for defined patient groups.
Special Access Scheme (SAS)
The Special Access Scheme allows healthcare practitioners to access certain unapproved therapeutic goods for individual patients under appropriate regulatory frameworks.
Treatment decisions remain the responsibility of the healthcare practitioner and should be based on a comprehensive assessment of the patient's medical history and clinical needs.
Yes.
Medicinal cannabis can be legally prescribed and supplied in Australia when obtained through approved medical and regulatory pathways.
Patients should only obtain medicinal cannabis products through legitimate healthcare channels and should follow the advice provided by their healthcare practitioner.
Patients may choose to discuss medicinal cannabis with their healthcare practitioner for a variety of reasons.
Many patients have explored multiple treatment approaches and wish to better understand whether cannabinoid-based therapies may form part of their overall healthcare plan.
Every patient is unique, and treatment decisions should be made in consultation with a qualified healthcare practitioner who can assess individual circumstances and discuss available options.
Medicinal cannabis is not a one-size-fits-all treatment.
Factors that may influence treatment decisions include:
Medical history
Current medications
Previous treatment experiences
Lifestyle considerations
Individual treatment goals
Healthcare practitioners can help determine whether medicinal cannabis may be appropriate and can provide ongoing monitoring and support where required.
Not all medicinal cannabis products are the same.
Some products contain:
CBD Only
These products primarily contain cannabidiol and little or no THC.
Balanced Products
These products contain varying ratios of CBD and THC.
THC Dominant Products
These products contain higher concentrations of THC and may require additional clinical considerations.
The choice of product depends on the patient's circumstances and the judgement of the prescribing practitioner.
Research into medicinal cannabis continues to evolve rapidly around the world.
Scientists and healthcare professionals continue to investigate:
Cannabinoids
Terpenes
The endocannabinoid system
Product formulations
Patient outcomes
Safety and quality standards
As evidence grows, our understanding of cannabis-based medicines continues to develop.
If you are interested in learning more about medicinal cannabis, the first step is to speak with a qualified healthcare practitioner.
A practitioner can review your medical history, discuss your treatment goals and provide guidance regarding available healthcare options.
Understanding medicinal cannabis begins with education, informed decision-making and professional medical advice.
Is medicinal cannabis the same as recreational cannabis?
No. Medicinal cannabis is supplied through regulated healthcare pathways and is used under medical supervision.
What is the difference between CBD and THC?
CBD is generally considered non-intoxicating, while THC is the primary psychoactive cannabinoid found in cannabis.
Can any doctor prescribe medicinal cannabis?
Access pathways vary and may depend on practitioner qualifications, authorisations and the products being considered.
Are medicinal cannabis products regulated?
Yes. Medicinal cannabis products supplied through Australian healthcare pathways are subject to regulatory requirements and quality standards.
Where can I learn more?
Speak with a qualified healthcare practitioner and review educational resources that explain medicinal cannabis, cannabinoids, terpenes and Australian access pathways.